Photo from wikipedia
Heart transplantation (HT) is the gold standard therapy for advanced heart failure, providing excellent long‐term outcomes. However, postoperative outcomes are limited by bleeding, infections, and primary graft dysfunction (PGD) that… Click to show full abstract
Heart transplantation (HT) is the gold standard therapy for advanced heart failure, providing excellent long‐term outcomes. However, postoperative outcomes are limited by bleeding, infections, and primary graft dysfunction (PGD) that contribute to early mortality after HT. HT candidates with pre‐existing hematologic disorders, bleeding, and clotting, may represent a higher risk population. We assessed the short‐ and long‐term outcomes of patients with pre‐existing hematologic disorders undergoing HT.
Journal Title: Clinical Transplantation
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!